Answers are grounded in this paper and cite their sources.
Background and Purpose 5‐HT 3 receptors play a central role in gut–brain signalling, and their hyperactivity is associated with pathologies ranging from chemotherapy‐induced nausea and vomiting to irritable bowel syndrome. While the principles governing 5‐HT 3 R orthosteric pharmacology are well established (spanning antagonists, partial agonists and full agonists), structural insights into allosteric mechanisms remain limited. This study aimed to investigate the mechanisms by which a positive modulator of 5‐HT 3 R, 5‐chloroindole, potentiates agonist response by fine‐tuning orthosteric activation of this receptor. Experimental Approach Here, we investigated the molecular basis of modulation by 5‐chloroindole (5‐CI), a selective positive allosteric modulator, using cryo‐EM and electrophysiology. We present 5‐HT 3A R structures in the presence of 5‐CI alone, as well as in combination with either submaximal concentrations of 5‐HT or saturating concentrations of the partial agonist SMP‐100. Key Results Our results reveal that 5‐CI potentiates 5‐HT 3 R through a distinct mechanism involving co‐occupancy of the orthosteric site and with additional modulation through an intersubunit site in the transmembrane domain. Conclusions and Implications This mode of action is reminiscent of benzodiazepine modulation in GABA A Rs, yet it notably occurs within homomeric binding sites. Together, these findings establish the structural basis for the previously reported ago‐allosteric mechanism of 5‐CI, which becomes functionally apparent only in the presence of agonistic ligands.
No takes yet. Share an insight, caveat, or question.
Stauffer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: